» Articles » PMID: 38407565

Iron Deficiency and Incident Heart Failure in Older Community-Dwelling Individuals

Overview
Journal ESC Heart Fail
Date 2024 Feb 26
PMID 38407565
Authors
Affiliations
Soon will be listed here.
Abstract

Aims: Among persons with prevalent heart failure (HF), iron deficiency has been linked to HF admissions, and intravenous iron replacement improves HF outcomes. Recent studies in persons with chronic kidney disease (CKD) demonstrate that iron deficiency is associated with incident HF. This study aimed to determine the relationship of iron status with incident HF in community-dwelling older adults irrespective of their kidney function.

Methods: In this case-cohort study, 1,006 Cardiovascular Health Study participants (785 from the random sub-cohort [including 193 HF cases] and 221 additional HF cases [N = 414 total HF cases]) aged ≥ 65 years without HF (41% with CKD), we used weighted Cox models to evaluate associations of iron status with incident HF. Participants were categorized based on quartiles of transferrin saturation and ferritin as "iron replete" (27.3%), "functional iron deficiency" (7.7%), "iron deficiency" (11.8%), "mixed iron deficiency" (5.6%), "high iron" (9.3%) and "non-classified" (38.1%), consistent with prior studies.

Results: Compared to older persons who were iron replete, those with iron deficiency were at higher risk of incident HF (HR 1.47; 1.02-2.11) in models adjusting for demographics, HF risk factors, and estimated glomerular filtration rate. Other iron categories did not associate with incident HF. The relationship of iron deficiency with incident HF did not differ by CKD status (interaction P value 0.2).

Conclusions: Among community-dwelling elders, iron deficiency is independently associated with incident HF, an association that was similar irrespective of CKD status. Our findings support conduct of clinical trials of iron replacement for prevention of HF in older adults with iron deficiency.

Citing Articles

Associations between heavy metal exposure and vascular age: a large cross-sectional study.

Feng Y, Liu C, Huang L, Qian J, Li N, Tan H J Transl Med. 2025; 23(1):4.

PMID: 39754096 PMC: 11697934. DOI: 10.1186/s12967-024-06021-w.


Iron Deficiency and Incident Heart Failure in Older Community-Dwelling Individuals.

Sharma S, Katz R, Chaves P, Hoofnagle A, Kizer J, Bansal N ESC Heart Fail. 2024; 11(3):1435-1442.

PMID: 38407565 PMC: 11098627. DOI: 10.1002/ehf2.14724.

References
1.
Patton K, Ellinor P, Heckbert S, Christenson R, deFilippi C, Gottdiener J . N-terminal pro-B-type natriuretic peptide is a major predictor of the development of atrial fibrillation: the Cardiovascular Health Study. Circulation. 2009; 120(18):1768-74. PMC: 4132053. DOI: 10.1161/CIRCULATIONAHA.109.873265. View

2.
Sharma S, Katz R, Chaves P, Hoofnagle A, Kizer J, Bansal N . Iron Deficiency and Incident Heart Failure in Older Community-Dwelling Individuals. ESC Heart Fail. 2024; 11(3):1435-1442. PMC: 11098627. DOI: 10.1002/ehf2.14724. View

3.
Ives D, Fitzpatrick A, Bild D, Psaty B, Kuller L, Crowley P . Surveillance and ascertainment of cardiovascular events. The Cardiovascular Health Study. Ann Epidemiol. 1995; 5(4):278-85. DOI: 10.1016/1047-2797(94)00093-9. View

4.
Graham F, Friday J, Pellicori P, Greenlaw N, Cleland J . Assessment of haemoglobin and serum markers of iron deficiency in people with cardiovascular disease. Heart. 2023; 109(17):1294-1301. PMC: 10423540. DOI: 10.1136/heartjnl-2022-322145. View

5.
Stack A, Mutwali A, Nguyen H, Cronin C, Casserly L, Ferguson J . Transferrin saturation ratio and risk of total and cardiovascular mortality in the general population. QJM. 2014; 107(8):623-33. PMC: 4108849. DOI: 10.1093/qjmed/hcu045. View